Pathogen research, infection control and lab innovation.
UV-C disinfection is often presented to UK laboratories as a simple final layer of assurance. In practice, the claim depends on room geometry, shadowing, surface cleanliness, delivered dose and tested safety controls. This article sets out a commissioning route that keeps UV-C within evidence-based limits.
A centrifuge can turn a cracked tube or a worn O-ring into a bench-wide aerosol challenge, yet pre-use checks are often remembered rather than recorded. This article sets out a short, auditable routine for UK containment laboratories that links daily bench behaviour to containment assurance.
An unexpected rise in positive microbiology results usually reflects a genuine clinical signal, but not always. This practical framework helps UK laboratories investigate possible pseudo-outbreaks in parallel with IPC action, so that contamination, carryover or process failure is identified without delaying care or causing unnecessary alarm.
Validation of an automated endoscope washer-disinfector is often treated as a commissioning milestone. In practice, it is a daily clinical control: the evidence that the first scope of the day has been processed through a cycle that was irrigated, dosed, sampled and recorded as intended. This article sets out a UK-focused morning assurance routine and periodic audit model for endoscopy and microbiology teams.
A revised susceptibility breakpoint can turn a susceptible result into a resistant one while the organism itself has not changed. This article sets out a UK laboratory workflow for making that shift visible to clinicians, from version-controlled comment codes to a structured 30-day review of receipt, understanding and action.
Pass boxes are often specified as containment interfaces and then managed as transfer hatches. This article sets out how UK containment laboratories can commission interlocks, pressure regimes, airflow and alarms as a single verified control, and keep that verification alive through routine monitoring.
A notifiable pathogen result is not closed when the message leaves the laboratory. This audit framework helps UK laboratories evidence receipt, escalation and ward-level action without turning assurance into a paper exercise.
An ultracold freezer failure is not merely an estates incident: it is a time-critical laboratory governance event with infection-control, scientific and regulatory consequences. This playbook sets out a UK-specific response covering alarm escalation, sample triage, dry-ice logistics and post-incident viability checks.
Negative-pressure isolation rooms are often treated as a fixed building feature, yet their performance depends on routine verification across estates, microbiology and infection control. This practical protocol sets out how UK teams can check pressure differentials, air-change performance and targeted air sampling before winter 2026/27—without overstating what any single sample can prove.
Community pharmacy testing is expanding, but a molecular result is only as trustworthy as the system around it. This framework sets out the analytical, environmental and governance checks UK laboratory teams should expect before near-patient assays are used for patient care.
Measles is no longer a theoretical line in the UK laboratory repertoire. This guide sets out a practical confirmation pathway for 2026, from oral fluid and throat swab PCR to salivary IgM, timing after rash onset, staff immunity and the UKHSA notification chain.
An unexpected parcel, a leaking specimen bag, a powder with no paperwork attached: the overwhelming majority will be innocent, but the judgement made in the first ten minutes is not. A practical guide to running a biosecurity tabletop that tests decisions rather than recall.
Rapid antimicrobial susceptibility testing can shave a day off a bloodstream infection result, and a day is worth having. But speed only becomes a susceptibility result when validation, breakpoints, reporting and the ward all move at the same pace. An opinionated adoption checklist for UK laboratory leaders.
Many UK cell and gene therapy facilities run environmental monitoring plans inherited from conventional pharmaceutical manufacturing, then discover that small batches and short campaigns break the assumptions behind them. This is a practical 2026 framework for risk-based monitoring, fragile trending data and proportionate contamination response.
Automated image analysis is moving from demonstration bench to routine work in UK microbiology. The equipment is usually the easy part; the defensible evidence package, the change-control discipline and the named human accountability are not. Here is what a credible 2026 validation route looks like under UKAS and UKCA expectations.
Hand hygiene, bench disinfection and autoclave cycles absorb most of the infection-control attention in UK laboratories, yet the water system can sit quietly colonised for years. This room-by-room walkthrough sets out how laboratory managers can audit taps, traps, drainage and point-of-use filters, document the findings, and decide when a result warrants escalation rather than a shrug.
Requests for phage susceptibility testing are arriving in UK laboratories with increasing frequency, often for patients whose options have narrowed sharply. A phagogram is a genuinely useful piece of evidence, but it is not a minimum inhibitory concentration, and the gap between a clear plaque and a clinical outcome is wider than many conversations currently acknowledge.
Autoclave validation is often treated as an annual paperwork exercise. In 2026, with audit scrutiny tightening, UK laboratories need to treat it as a live infection-control control point — from load configuration and biological indicators to staff competency and defensible records.
Candida auris preparedness should not begin with a ward outbreak. UK clinical microbiology laboratories need a practical playbook covering identification limits, environmental sampling requests, infection prevention communication and the gap between national guidance and bench reality.
Home-collected samples for STIs, respiratory infections and microbiome testing are moving from novelty to routine in parts of the UK. Laboratories need a disciplined framework for validation, instruction design, transport stability and result follow-up before convenience outruns clinical governance.